The Agilent 8697 Headspace Sampler-XL Tray has a 120-vial capacity.
Agilent released an announcement of its Agilent 8697 Headspace Sampler -XL Tray, which features 120-vial capacity, in addition to their existing 48-vial capacity tray. In addition to the capacity increase, the new tray includes new instrument intelligence features that are designed for increased uptime and operator ease-of-use relative to its predecessor.
According to a press release from May 1, 2023, the device’s intelligence features are enabled through self-monitoring operations and guiding operators that use various troubleshooting and maintenance procedures. The system performs automated system checks, including leak checks, early maintenance feedback, and self-diagnostics. Additionally, the new tray can be run with alternate carrier gasses due to the separation of vial pressurization and the sample loop for added method flexibility.
“Labs that run headspace GC [gas chromatography] systems know that if they encounter problems during a sequence, and the vials are punctured, they may have to rerun or recollect samples,” said Mike Zhang, vice-president and general manager of Agilent’s Gas Phase Separations Division. “The 8697 and now the 8697 Headspace Sampler-XL Tray virtually eliminate that problem. The complete GC headspace system checks to ensure that the system and data quality are up to SOP [standard operating procedure] standards, avoiding recollection of samples and reruns.”
Source: Agilent
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.